Background Chronic obstructive pulmonary disease (COPD) is a leading cause of global mortality, yet existing risk prediction models remain limited. This study aimed to develop and validate a ...
The causal biomarkers for metabolic dysfunction-associated steatotic liver disease (MASLD) and their clinical value remain ...
This infographic explores a workflow that can bring proteomics to any lab in nine easy steps. Discover how to run a ...
CHICAGO--(BUSINESS WIRE)--Nucleai, an AI-powered spatial biomarker and diagnostics company, today announced the launch of its deep learning model that automates the normalization of high-plex imaging ...
“This collaboration with Inova underscores the expanding applications of our RPPA technology in solid tumors,” said Faith Zaslavsky, President and CEO of Ignite Proteomics. “By partnering with Inova’s ...
Multi-omics service company Panome Bio launched its global phosphoproteomics platform, which has been created to analyze both protein abundance and protein phosphorylation events, a key regulatory ...